# China NMPA Inspection - Guangzhou Aolai Cosmetics Co., Ltd. - March 21, 2018

Source: https://www.globalkeysolutions.net/records/china_inspection/guangzhou-aolai-cosmetics-co-ltd/8a525f57-6426-46a9-8e86-8bea823e878b/
Source feed: China

> China NMPA unannounced inspection for Guangzhou Aolai Cosmetics Co., Ltd. published March 21, 2018. An unannounced inspection by the State Food and Drug Administration (NMPA) revealed significant deficiencies at Guangzhou Daifen Cosmetics Co., Ltd., 

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement No. 59 of 2018 from the State Administration of Customs regarding the order for Guangzhou Daifen Cosmetics Co., Ltd. to suspend production for rectification.
- Company Name: Guangzhou Aolai Cosmetics Co., Ltd.
- Publication Date: 2018-03-21
- Product Type: Cosmetics
- Summary: An unannounced inspection by the State Food and Drug Administration (NMPA) revealed significant deficiencies at Guangzhou Daifen Cosmetics Co., Ltd., announced on March 19, 2018. The inspection identified numerous violations of the "Cosmetic Production Licensing Work Specifications." Key issues encompassed organizational and personnel failures, including part-time management, insufficient and untrained staff, and a lack of health checks. Quality management was severely lacking, with incomplete production, inspection, training, and sales records; absence of inspection for raw, packaging, and intermediate materials; and missing original inspection documentation for finished products. Facility management also presented critical problems: production areas were cluttered and unsanitary, environmental controls were absent in critical storage areas, and equipment cleaning and maintenance were inadequate, with residues remaining and calibration records expired or non-existent. Furthermore, material and product management issues included a lack of traceability, inventory controls, and supplier files. Most critically, an unregistered product was found without proper manufacturer identification. Production process failures included undefined product batches, making traceability impossible, and missing batch production and inspection records for various products. As a result, the company has been ordered to immediately suspend all production and sales activities. Resumption is contingent upon full rectification of all identified deficiencies and a successful follow-up inspection by the Guangdong Provincial Food and Drug Administration. The NMPA will also pursue serious action regarding the suspected illegal production activities.

Company: https://www.globalkeysolutions.net/companies/guangzhou-aolai-cosmetics-co-ltd/b249f321-1aa8-43a4-8fbd-0a94215c7beb/